Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Dr. Timothy T. GoodnowPresident, CEO & Director | -28,60k | 166,44k | Sale to Issuer | 5,82 | 454,36k | -5,92% |
| 2026-05-15 | Dr. Mukul JainCOO | -13,68k | 79,62k | Sale to Issuer | 5,82 | 165,38k | -7,64% |
| 2026-05-15 | Dr. Francine Ratner KaufmanChief Medical Officer & Director | -6,06k | 35,26k | Sale to Issuer | 5,82 | 81,76k | -6,90% |
| 2026-05-15 | Mr. Frederick T. SullivanCFO, Secretary & Treasurer | -9,01k | 52,41k | Sale to Issuer | 5,82 | 89,15k | -9,17% |
| 2026-05-15 | Mr. Kenneth L. HortonGeneral Counsel & Corporate Development Advisor | -7,32k | 42,60k | Sale to Issuer | 5,82 | 95,15k | -7,14% |
| 2026-05-12 | Mr. Douglas A. RoederIndependent Non-Management Director | 22,69k | 126,13k | Achat | 5,56 | 144,64k | 18,60% |
| 2026-03-13 | Mr. Douglas A. RoederIndependent Non-Management Director | 17,50k | 100,28k | Achat | 5,73 | 114,16k | 18,10% |
| 2026-03-13 | Dr. Timothy T. GoodnowPresident, CEO & Director | 17,23k | 99,73k | Achat | 5,79 | 422,23k | 4,25% |
| 2025-11-15 | Mr. Kenneth L. HortonGeneral Counsel & Corporate Development Advisor | -6,00k | 37,54k | Sale to Issuer | 6,26 | 87,32k | -6,43% |
| 2025-11-15 | Dr. Mukul JainCOO | -10,32k | 64,58k | Sale to Issuer | 6,26 | 150,47k | -6,42% |
| 2025-11-15 | Dr. Timothy T. GoodnowPresident, CEO & Director | -27,07k | 169,44k | Sale to Issuer | 6,26 | 405,01k | -6,26% |
| 2025-11-15 | Dr. Francine Ratner KaufmanChief Medical Officer & Director | -4,61k | 28,83k | Sale to Issuer | 6,26 | 75,89k | -5,72% |
| 2025-11-15 | Mr. Frederick T. SullivanCFO, Secretary & Treasurer | -6,40k | 40,08k | Sale to Issuer | 6,26 | 79,72k | -7,43% |
| 2025-11-10 | Dr. Steven V. EdelmanIndependent Non-Management Director | 10,00k | 65,50k | Achat | 6,55 | 69,14k | 16,91% |
| 2025-11-07 | Mr. Frederick T. SullivanCFO, Secretary & Treasurer | 5,42k | 31,84k | Achat | 5,88 | 63,19k | 9,37% |
| 2025-11-07 | Mr. Douglas A. RoederIndependent Non-Management Director | 15,00k | 87,45k | Achat | 5,83 | 94,16k | 18,95% |
| 2025-11-07 | Dr. Timothy T. GoodnowPresident, CEO & Director | 17,21k | 101,02k | Achat | 5,87 | 301,25k | 6,06% |
| 2025-06-16 | Dr. Francine Ratner KaufmanChief Medical Officer & Director | -1,44k | 14,72k | Sale to Issuer | 10,20 | 67,61k | -2,09% |
| 2025-06-16 | Dr. Mukul JainCOO | -2,94k | 29,97k | Sale to Issuer | 10,20 | 132,19k | -2,17% |
| 2025-06-16 | Dr. Timothy T. GoodnowPresident, CEO & Director | -3,98k | 40,62k | Sale to Issuer | 10,20 | 354,14k | -1,11% |
| 2025-06-16 | Mr. Kenneth L. HortonGeneral Counsel & Corporate Development Advisor | -1,79k | 18,25k | Sale to Issuer | 10,20 | 78,18k | -2,24% |
| 2025-06-16 | Mr. Frederick T. SullivanCFO, Secretary & Treasurer | -1,36k | 13,90k | Sale to Issuer | 10,20 | 57,77k | -2,31% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.